Insurance notes: ask about the exact use
“Will my plan pay for it?” is a good start. Give the insurer the medicine’s name, its form (shot or pill), and the reason you need it.
Facts checked September 26, 2026.
“Which medicine would my plan pay for?”
The FDA, the US drug regulator, had approved neither cagrilintide nor CagriSema at the September 28, 2026 check.
Before talking about payment, ask what medicine a care quote actually means. Keep the name in writing for the insurer.
Ask whether the plan has a covered-drug list and whether it needs to agree in advance. Ask what your part of the bill would be.
The basic Medicare drug rule
At the September 26, 2026 check, the basic Medicare Part D benefit excluded medicines used for weight loss; Part D is Medicare’s prescription-drug coverage.
A drug used for another approved condition can be covered, subject to the plan’s rules.
That does not mean every plan pays for every approved use.
A separate temporary programme
Medicare offers a temporary programme called the GLP-1 Bridge to help some people with Part D drug coverage pay for weight-care medicines.
GLP-1 is a hormone: a chemical message from the body, with effects on hunger and blood sugar.
The dates checked on September 26, 2026 are July 1, 2026 for the start and December 31, 2027 for the end, with a monthly copay of $50.
The part of a bill paid by the patient is called a copay; this programme sits outside the usual Part D benefit.
It has not changed the basic exclusion for weight-loss use.
Cagrilintide is not among the programme’s covered products as of September 26, 2026.
“Could I qualify for that programme?”
The covered medicines are Foundayo pills, Wegovy shots or pills, and Zepbound in a device called the KwikPen.
Other Zepbound pens and its small bottles of medicine are not included.
The rules checked September 26, 2026 require age 18 or older and a qualifying Part D plan.
A BMI of at least 35 is one way to meet the weight rule; BMI uses a person’s height and weight to give a number.
Some people with a lower BMI can qualify if they also have one of the health problems listed in the programme rules.
For people who have type 2 diabetes, medicine is considered under ordinary Part D coverage, so they cannot qualify for the Bridge.
Receiving Part D payment for one of these medicines in 2026 rules out using the Bridge in 2026.
Payment requires both a prescription and advance approval of the request.
These are some of the rules, not a full eligibility check. Ask your doctor: “Do my weight and health meet the Bridge rules?” Ask your Part D plan: “Is my plan included, and does my earlier coverage affect this?”
Find the full Medicare Bridge rulesThe payment has a catch
Under the Bridge rules checked September 26, 2026, payments of $50 are excluded from the amount counted toward your yearly Part D spending cap.
The Part D deductible does not apply to the programme.
A plan begins helping with costs after the amount called a deductible has been paid.
The programme has no low-income subsidy, meaning extra help with this copay for people with low incomes.
Ask your doctor and Part D plan about the exact medicine: does it come as a pill or shot, and which injection device does it use? A coverage headline cannot settle what you would pay.
Find the official Medicare programme pageKeep care fees in the conversation
Ask separately about the visit or membership. Ask what happens to that charge while a coverage decision is pending or if medicine is not prescribed.
Build questions about the whole bill